Statera BioPharma Inc (STAB)

[ash111]

that's what i'm waiting for+ has more phase 2 drugs on going.
biodefense treatment, entolimod, is now on the fast track toward a Marketing Authorization Application (MAA). 3.7m float, 10.7m O/S, 61% ownership. No debt. Per 10Q: fully funded until a year ahead. There is never 100% guarantee w/ bios but to me it seems like a done deal ( MAA). In this case, thats at least $20 stock if you ask me.